| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/29/2011 | US20110237801 Substituted pyrazoles, compositions containing these, method of production and use |
| 09/29/2011 | US20110237800 Herbicide triazolylpyridine ketones |
| 09/29/2011 | US20110237792 Quinoline derivatives and their use as 5-ht6 ligands |
| 09/29/2011 | US20110237791 2-pyridone compounds |
| 09/29/2011 | US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/29/2011 | US20110237628 Cyclopentyl- and cycloheptylpyrazoles |
| 09/29/2011 | US20110237627 Methods of synthesizing anatabine |
| 09/29/2011 | US20110237624 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 09/29/2011 | US20110237622 Renin inhibitors |
| 09/29/2011 | US20110237621 Macrocyclic Inhibitors of Hepatitis C Virus |
| 09/29/2011 | US20110237610 Quinazoline Derivatives as Antiproliferative Agents |
| 09/29/2011 | US20110237600 Compounds for improving learning and memory |
| 09/29/2011 | US20110237598 New compounds |
| 09/29/2011 | US20110237594 Fungicide heretocyclyl-triazinyl-amino derivatives |
| 09/29/2011 | US20110237590 Pyridine-3-carboxyamide derivative |
| 09/29/2011 | US20110237586 Biaryl compositions and methods for modulating a kinase cascade |
| 09/29/2011 | US20110237584 Kynurenine production inhibitor |
| 09/29/2011 | US20110237579 Inhibitors of hcv ns5a |
| 09/29/2011 | US20110237578 Amide compounds, compositions and uses thereof |
| 09/29/2011 | US20110237576 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having bace1-inhibiting activity |
| 09/29/2011 | US20110237573 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
| 09/29/2011 | US20110237571 Phthalazine derivatives |
| 09/29/2011 | US20110237559 6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1 |
| 09/29/2011 | US20110237528 Compositions and methods comprising imidazole and triazole derivatives |
| 09/29/2011 | US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof |
| 09/29/2011 | US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor |
| 09/29/2011 | US20110235150 Electrochromic material and electrochromic device including the same |
| 09/29/2011 | US20110233477 Dye sensitised solar cell |
| 09/29/2011 | CA2794307A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| 09/29/2011 | CA2794145A1 Analogues for the treatment or prevention of flavivirus infections |
| 09/29/2011 | CA2794086A1 Heterocyclic compounds useful for kinase inhibition |
| 09/29/2011 | CA2794018A1 Compositions and methods for the treatment of degenerative diseases |
| 09/29/2011 | CA2794004A1 Imaging agents for detecting neurological disorders |
| 09/29/2011 | CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793949A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793920A1 Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salt |
| 09/29/2011 | CA2789778A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 09/29/2011 | CA2789200A1 Pharmaceutically active disubstituted triazine derivatives |
| 09/28/2011 | EP2368890A1 Hepatitis C virus inhibitors |
| 09/28/2011 | EP2368889A1 Inhibitors of tyrosine kinases |
| 09/28/2011 | EP2368882A1 Anti-infective pyrimidines and uses thereof |
| 09/28/2011 | EP2368880A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2368550A1 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases |
| 09/28/2011 | EP2367817A1 Inhibitors of diacylglycerol acyltransferase |
| 09/28/2011 | EP2367814A1 New compounds 578 |
| 09/28/2011 | EP2367813A1 Antiviral compounds |
| 09/28/2011 | EP2367812A2 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4trifluoromethoxy-1h-indol-3-yl]methanone as an inhibitor of mast cell tryptase |
| 09/28/2011 | EP2367803A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 09/28/2011 | EP2367800A2 New compounds |
| 09/28/2011 | EP2367799A1 New compounds |
| 09/28/2011 | EP2367797A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/28/2011 | EP2367426A1 Phenazopyridine compounds |
| 09/28/2011 | EP2148876B1 Pyrazolone derivatives as pde4 inhibitors |
| 09/28/2011 | EP1926722B1 Substituted benzimidazoles as kinase inhibitors |
| 09/28/2011 | EP1912972B1 Substituted imidazole compounds as ksp inhibitors |
| 09/28/2011 | EP1697344B1 Hiv protease inhibiting compounds |
| 09/28/2011 | CN1910171B Method for preparation of 6-11 bicyclo erythromycin derivant |
| 09/28/2011 | CN1795174B Novel substituted 3-sulfur indoles |
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/28/2011 | CN102203084A Nilotinib hci crystalline forms |
| 09/28/2011 | CN102203083A Compounds and compositions as kinase inhibitors |
| 09/28/2011 | CN102203082A Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics |
| 09/28/2011 | CN102203081A Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 09/28/2011 | CN102203080A Heterocyclically substituted anilinopyrimidines as fungicides |
| 09/28/2011 | CN102203079A Picolinamide derivatives as kinase inhibitors |
| 09/28/2011 | CN102203078A P38 MAPK kinase inhibitor |
| 09/28/2011 | CN102203077A ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain |
| 09/28/2011 | CN102203076A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/28/2011 | CN102203075A Bicyclic kinase inhibitors |
| 09/28/2011 | CN102203074A Aryl GPR119 agonists and uses thereof |
| 09/28/2011 | CN102203068A Cyclohexane derivative and pharmaceutical use thereof |
| 09/28/2011 | CN102203067A Hedgehog pathway modulators |
| 09/28/2011 | CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists |
| 09/28/2011 | CN102203064A Novel benzamides, production thereof, and use thereof as medicaments |
| 09/28/2011 | CN102203063A Carbazole compounds and therapeutic uses of the compounds |
| 09/28/2011 | CN102203061A Selective seprase inhibitors |
| 09/28/2011 | CN102203060A 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/28/2011 | CN102203059A Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/28/2011 | CN102201432A Organic light-emitting device and method of manufacturing the same |
| 09/28/2011 | CN102199146A Preparation method for N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine |
| 09/28/2011 | CN102199145A Compound for the treatment of gastrointestinal disease |
| 09/28/2011 | CN102199144A Benzimidazole derivatives |
| 09/28/2011 | CN102199143A New preparation method for crystal with imatinibmesylate alpha crystal form |
| 09/28/2011 | CN102199119A Oxime ester photoinitiators |
| 09/28/2011 | CN101532992B Method for detecting purithiamine in blood by efficient liquid chromatography |
| 09/28/2011 | CN101531631B Substituted pyridinones as modulators of p38 map kinase |
| 09/28/2011 | CN101440062B Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe |
| 09/28/2011 | CN101184748B Process for the synthesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine |
| 09/28/2011 | CN101160303B 1-(2H)-isoquinolone derivative |
| 09/27/2011 | US8026368 Hydrazide compounds and thrombopoietin receptor activators |
| 09/27/2011 | US8026360 Substituted pyridazines as stearoyl-CoA desaturase inhibitors |
| 09/27/2011 | US8026359 Fungicidal heterocyclic amines |
| 09/27/2011 | US8026260 Histone deacetylase inhibitors with aryl-pyrazolyl-motifs |
| 09/27/2011 | US8026259 e.g. {5-Chloro-2-[4-(2-oxo-2,3-dihydro-benzooxazol-7-yl)-piperidine-1-carbonyl]-1H-indol-7-yl}-acetonitrile; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, obsessive compulsive disorder |
| 09/27/2011 | US8026258 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/27/2011 | US8026257 Substituted heterocyclic ethers and their use in CNS disorders |
| 09/27/2011 | US8026256 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 09/27/2011 | US8026254 Therapeutic agents useful for treating pain |
| 09/27/2011 | US8026248 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS |